ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
Jost
L M
LM
Oncology, Kantonsspital, CH-4101 Bruderholz/BL, Switzerland.
Stahel
R A
RA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D015994:Incidence; D009367:Neoplasm Staging; D012008:Recurrence; D018570:Risk Assessment; D014747:Vinblastine / Q000008:administration & dosage
D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin